'This recall is because the efficacy of the product cannot be guaranteed after 12 months' - VMD.
Vets and wholesalers urged to examine their inventory immediately
The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for batches of the antibiotic Clavubactin, manufactured by Le Vet Pharma.
In a news release, the VMD writes: ‘We wish to make wholesalers and veterinary surgeons aware that Le Vet Pharma has issued a recall for batches of Clavubactin 50/12.5mg (Vm 19994/4028), Clavubactin 250/62.5mg (Vm 19994/4026), Clavubactin 500/125mg (Vm 19994/4027), all distributed by Animalcare and Dechra.
‘During routine stability testing the above-mentioned products do not fulfil the mandatory testing requirements at 24 months. This recall is because the efficacy of the product cannot be guaranteed after 12 months.’
The recall affects the following batches:
Product names |
Batch numbers |
Expiry |
Clavubactin 50/12.5 mg |
19D82 |
04-2021 |
|
18D11 |
04-2020 |
|
18G32 |
07-2020 |
Clavubactin 250/62.5 mg |
19D83 |
04-2022 |
|
17F46 |
06-2020 |
|
17H35 |
08-2020 |
|
18D13 |
04-2021 |
Clavubactin 500/125 mg |
19D88 |
04-2022 |
|
17C80 |
03-2020 |
|
17F47 |
06-2020 |
|
17H38 |
08-2020 |
|
18D17 |
04-2021 |
|
18D18 |
04-2021 |
|
18G34 |
04-2022 |
Veterinary surgeons and wholesalers are urged to examine their inventory without delay and quarantine products subject to this recall.
For more information, please contact the relevant distributor:
Animalcare: Sameer Hashmi: shashmi@animalcare.co.uk
Dechra: Tracey Smith: tracey.smith@dechra.com